• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血管肉瘤样恶性纤维组织细胞瘤]

[Angiomatoid malignant fibrous histiocytoma].

作者信息

Fan Q, Allen P W

机构信息

Department of Pathology, First Affilated Hospital of Nanjing Medical University.

出版信息

Zhonghua Bing Li Xue Za Zhi. 1996 Feb;25(1):30-2.

PMID:8762438
Abstract

By clinical, pathologic and immunohistochemical study on aniomatoid malignant fibrous histiocytoma, which is a relatively uncommon soft tissue tumor described by Enzinger in 1979, and often misdiagnosed, we are reporting 32 cases of this lesion. The distinctive histopathology were: (1) Cystic change filled with hemorrhagic fluid or blood, (2) surrounded by nests of fibroblastlike and histocyte-like cells and (3) intermingled with chronic inflammatory cells, (4) often surrounded by a fibrous pseudocapsule. Immunohistochemical staining done in 4 cases showed all to be positive in lysozyme, three positive in Mac 387 and CD 68. These results support their histiocytic origin. Follow-up information was available in 25 of 32 cases. All the 25 patients were alive, 4 with recurrence (16%), 1 with metastasis (4%). These results concur with the opinion that intrinsically, this is a low grade tumor.

摘要

通过对1979年由恩津格描述的相对罕见的软组织肿瘤——非典型性恶性纤维组织细胞瘤进行临床、病理及免疫组织化学研究,该肿瘤常被误诊,我们报告了32例此病变。其独特的组织病理学表现为:(1)充满血性液体或血液的囊性改变;(2)被成纤维细胞样和组织细胞样细胞巢所围绕;(3)与慢性炎症细胞混合;(4)常被纤维性假包膜所包绕。对4例进行的免疫组织化学染色显示,所有病例溶菌酶均呈阳性,3例Mac 387和CD 68呈阳性。这些结果支持它们的组织细胞起源。32例中有25例可获得随访信息。所有25例患者均存活,4例复发(16%),1例转移(4%)。这些结果与该肿瘤本质上是低度恶性肿瘤的观点一致。

相似文献

1
[Angiomatoid malignant fibrous histiocytoma].[血管肉瘤样恶性纤维组织细胞瘤]
Zhonghua Bing Li Xue Za Zhi. 1996 Feb;25(1):30-2.
2
Angiomatoid malignant fibrous histiocytoma. A follow-up study of 108 cases with evaluation of possible histologic predictors of outcome.血管样恶性纤维组织细胞瘤。108例随访研究及对可能的组织学预后预测因素的评估。
Am J Surg Pathol. 1990 Dec;14(12):1126-32.
3
Angiomatoid "malignant" fibrous histiocytoma: a clinicopathologic study of 158 cases and further exploration of the myoid phenotype.血管样“恶性”纤维组织细胞瘤:158例临床病理研究及肌样表型的进一步探索
Hum Pathol. 1999 Nov;30(11):1336-43. doi: 10.1016/s0046-8177(99)90065-5.
4
Angiomatoid (malignant) fibrous histiocytoma: a peculiar low-grade tumor showing immunophenotypic heterogeneity and ultrastructural variations.
Pathol Int. 2000 Sep;50(9):731-8. doi: 10.1046/j.1440-1827.2000.01112.x.
5
[Angiomatoid fibrous histiocytoma: report of 5 cases with review of literature].[血管样纤维组织细胞瘤:5例报告并文献复习]
Zhonghua Bing Li Xue Za Zhi. 2010 Apr;39(4):245-8.
6
Myxoid variant of so-called angiomatoid "malignant fibrous histiocytoma": clinicopathologic characterization in a series of 21 cases.所谓的“血管肌纤维母细胞瘤样”黏液样型:21 例系列病例的临床病理特征。
Am J Surg Pathol. 2014 Jun;38(6):816-23. doi: 10.1097/PAS.0000000000000172.
7
Angiomatoid malignant fibrous histiocytoma: cytologic, immunohistochemical, ultrastructural, and flow cytometric study of 20 cases.血管样恶性纤维组织细胞瘤:20例的细胞学、免疫组织化学、超微结构及流式细胞术研究
Mod Pathol. 1990 Jul;3(4):479-87.
8
[Angiomatoid malignant fibrous histiocytoma. Clinico-pathologic and immunohistochemical study of a case].[血管样恶性纤维组织细胞瘤。1例临床病理及免疫组化研究]
Minerva Chir. 1993 Jun 15;48(11):649-52.
9
Angiomatoid malignant fibrous histiocytoma revisited. An immunohistochemical and DNA ploidy analysis.再探血管样恶性纤维组织细胞瘤:免疫组织化学及DNA倍体分析
Am J Dermatopathol. 1997 Jun;19(3):223-7. doi: 10.1097/00000372-199706000-00004.
10
Angiomatoid "malignant fibrous histiocytoma": an immunohistochemical study indicative of myoid differentiation.
Hum Pathol. 1991 Jun;22(6):563-8. doi: 10.1016/0046-8177(91)90233-f.

引用本文的文献

1
Intracranial temporal bone angiomatoid fibrous histiocytoma: illustrative case.颅内颞骨血管样纤维组织细胞瘤:病例说明
J Neurosurg Case Lessons. 2021 Jan 18;1(3):CASE2026. doi: 10.3171/CASE2026.